Abiraterone Acetate Arbitus Tablet 250mg

Get a Price/Quote

MOQ : 10 Packs

Abiraterone Acetate Arbitus Tablet 250mg Specification

Indication
Prostate cancer treatment

Salt Composition
Abiraterone Acetate

Dosage Form
Tablet

Feature
Prescription medicine, suitable for regulated markets

Ingredients
Abiraterone Acetate, Excipients

Application
Oral, for the treatment of metastatic castration-resistant prostate cancer (mCRPC)

Physical Color/Texture
Film-coated tablet

Storage Instructions
Store below 30C, protect from moisture and light

Shelf Life
24 months

Administration Route
Oral

Brand Name
Arbitus

Marketed By
BDR Lifesciences Pvt Ltd

Prescription Required
Yes

Batch Number/Expiry Date Details
Available on box

Strength
250 mg

Common Packaging
Box packaging

Packaging Size
120 Tablets per box

Country of Approval
Approved for usage in Canada, Europe, UK, USA, Australia

Type of Medicine
Antineoplastic agent

Manufactured By
BDR Pharmaceuticals

Regulatory Status
I.P. (Indian Pharmacopeia) standard

Abiraterone Acetate Arbitus Tablet 250mg Trade Information

Minimum Order Quantity
10 Packs

Delivery Time
5-7 Days

About Abiraterone Acetate Arbitus Tablet 250mg

Discover significant savings with Arbitus Abiraterone Acetate 250mg Tablet, a sought-after solution in the world of prostate cancer care. Manufactured by BDR Pharmaceuticals and adhering to superlative I.P. standards, each box contains 120 of the finest film-coated tablets. This prescription-only antineoplastic agent is approved for use in regulated markets including Canada, Europe, UK, USA, and Australia. Pick yours today for trusted treatment of metastatic castration-resistant prostate cancer (mCRPC). Get benefits from a product that exemplifies reliability and quality, ensuring peace of mind for healthcare professionals and patients alike.

Comprehensive Application & Distinctive Features of Arbitus

Arbitus Abiraterone Acetate 250mg is designed for oral administration, making it simple and convenient for patients and caregivers alike. As a prescription-only, film-coated tablet, it employs the superlative qualities of abiraterone acetate and select excipients, all tailored for the treatment of metastatic castration-resistant prostate cancer (mCRPC). The site of application is internal (oral cavity), while its discreet surface ensures patient comfort. Storage below 30C keeps its properties intact until use.

Competitive Rates, Flexible Payment, and Market Offers

When you pick Arbitus Abiraterone Acetate 250mg, you get attractive FOB port options, with shipments primarily routed through India's key ports. Payment terms are versatile, supporting reliable exchange via standard banking and transfer methods. Our main domestic market is India, where we consistently offer great rates for both suppliers and end users, ensuring that sought-after treatments remain accessible and cost-effective while adhering to the highest pharmaceutical standards.

FAQ's of Abiraterone Acetate Arbitus Tablet 250mg:

Q: How is Arbitus Abiraterone Acetate 250mg administered?

A: Arbitus Abiraterone Acetate 250mg Tablet is administered orally. It should be taken exactly as prescribed by a healthcare professional, typically with water and without food, to ensure maximum efficacy in the treatment of metastatic castration-resistant prostate cancer.

Q: What makes Arbitus Abiraterone Acetate 250mg a sought-after product in regulated markets?

A: Arbitus stands out due to its approval for usage in major markets like Canada, Europe, UK, USA, and Australia, and its adherence to the Indian Pharmacopeia standard. Manufactured by BDR Pharmaceuticals, it embodies the highest quality and reliability for prostate cancer treatment.

Q: When should Arbitus Abiraterone Acetate 250mg be used?

A: This medication is indicated for adult patients with metastatic castration-resistant prostate cancer (mCRPC). The timing and dosage follow strict medical guidelines and should commence only on a doctor's recommendation and prescription.

Q: Where can I find the batch number and expiry date details for Arbitus?

A: Batch number and expiry date details are clearly mentioned on each box of Arbitus Abiraterone Acetate 250mg Tablets, ensuring transparency and traceability for users and pharmacists alike.

Q: What is the benefit of using Arbitus Abiraterone Acetate 250mg for prostate cancer?

A: Arbitus provides a superlative, targeted approach for metastatic castration-resistant prostate cancer, inhibiting specific androgen biosynthesis and helping to manage disease progression more effectively, with quality assurance from a leading pharmaceutical manufacturer.

Tell us about your requirement